Success Metrics

Active Trials
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph not_applicable
2
33%
Ph phase_3
1
17%
Ph phase_2
2
33%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Withdrawn1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 31 (16.7%)
N/A2 (33.3%)

Trials by Status

unknown350%
withdrawn117%
not_yet_recruiting117%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

NCT05604638
not_yet_recruitingphase_2

Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke

NCT06587347
withdrawnphase_1

Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke

NCT04818944
unknownphase_2

Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke

NCT04491695
unknownnot_applicable

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

NCT03406832
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05604638Phase 3

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

Recruiting
NCT06587347Phase 2

Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke

Not Yet Recruiting
NCT04818944Phase 1

Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke

Withdrawn
NCT04491695Phase 2

Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke

Unknown
NCT03406832Not Applicable

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

Unknown
NCT03406819Not Applicable

Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6